ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Eligible patients had COPD, were ages 40 or older ... study inhaler or an inhaled corticosteroid-LAMA-LABA combination via separate inhalers. The cohort included 87,751 individuals, from which ...

In parallel with the emergence of combination inhalers, research has revealed that, for some COPD patients, the blend of ...

umeclidinium and vilanterol by the end of the year in COPD. The combination is an inhaled corticosteroid, long acting muscarinic antagonist and a long-acting beta agonist. It met its co-primary ...

A new study suggests COPD patients experience improved ... Breezhaler from other COPD treatments, such as inhaled steroid-containing combination therapies," said Vasant Narasimhan, Global Head ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...

Medicare Part D and Medicare Advantage (Part C) plans with drug coverage typically cover inhalers for COPD. But you may still be responsible for a portion of the cost. If you have chronic ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

Karpel JP; Kotch A; Zinny M; Pesin J; Alleyne W To evaluate the role of inhaled ipratropium bromide alone vs oral theophylline plus inhaled beta-agonist or the combination of all three in patients ...

The demand for inhalation and nasal spray generic drugs is growing as these medications provide affordable and effective treatment options for respiratory ailments like asthma, COPD, and allergies.